Manipulating immune responses with immunosuppressive agents that target NFAT

Immunity

Volumn 12, Issue 4, 2000, Pages 359-372

  Kiani, Alexander ^a   Rao, Anjana ^b   Aramburu, Jose ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ALLERGIC ASTHMA; ALLOGENIC BONE MARROW TRANSPLANTATION; DRUG ACTIVITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK;

EID: 0033698581     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80188-0     Document Type: Review

References (117)

1. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells
2. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT
3. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A
4. Calcineurin: Regulation and function
5. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression
6. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
7. Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells
8. CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation
9. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction
10. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3
11. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells
12. Biological effects of cyclosporin A: A new antilymphocytic agent
13. The cyclosporin A-sensitive nuclear factor of activated T cells (NFAT) proteins are expressed in vascular smooth muscle cells
14. Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency
15. Structure of the DNA-binding domains of NFAT, Fos and Jun bound to DNA
16. 2-terminal kinase pathway
17. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
18. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway
19. Requirement for transcription factor NFAT in interleukin-2 expression
20. Nitric oxide in excitable tissues: Physiological roles and disease
21. Alternative polyadenylation events contribute to the induction of NF-ATc in effector cells
22. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT
23. 2+, calcineurin, and NF-AT
24. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells
25. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
26. 2+ response amplitude and duration
27. Calcium oscillations increase the effficiency and specificity of gene expression
28. Defective T cell differentiation in the absence of Jnk1
29. Dephosphorylation of tau protein and alzheimer paired helical filaments by calcinetrin and phosphatase-2A
30. The immunosuppressive and toxic effects of FK-506 are mechanistically related: Pharmacology of a novel antagonist of FK-506 and rapamycin
31. Characterization of T cell mutants with defects in capacitative calcium entry: Genetic evidence for the physiological roles of CRAC channels
32. P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells
33. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings
34. Characterization of a novel calcium response element in the glucagon gene
35. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP)
36. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons
37. T cell costimulatory blockade: New therapies for transplant rejection
38. Newer immunosuppressive drugs: A review
39. Cdk phosphorylation triggers sequent al intramolecular interactions that progressively block Rb functions as cells move through G1
40. Expression of the transcription factor NFATp in a neuronal celt line and in the murine nervous system
41. A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis
42. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice
43. Cyclosporin induces cancer progression by a cell-autonomous mechanism
44. Blood levels of TGFβ in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine
45. Nucleoxcytoplasmic shuttling factors including Ran and CFM1 mediate nuclear export of NFAT in vitro
46. Transforming growth factor (TGF)-β mimics and anti-TGF-β antibody abrogates the in vivo effects of cyclosporine
47. Tacrolimus Induces increased expression of transforming growth factorb1 in mammalian lymphoid as well as nonlymphoid cells
48. Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1
49. FK-506, a novel immunosuppressant isolated from a streptomyces
50. Rapid targeting of nuclear proteins to the cytoplasm
51. Roles of phosphorylation sites in regulating activity of the transcription factor Pho4
52. Cain, a novel physiologic protein inhibitor of calcineurin
53. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
54. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx
55. Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism
56. Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells: Demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction
57. 2+ spike frequency can optimize gene expression
58. Two independent calcineurin-binding regions in the N-terminal domain of murine NF-ATx1 recruit calcineurin to murine NF-ATx1
59. T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1
60. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity
61. Risk of neoplasia in renal transplant patients
62. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun
63. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: Possible lack of relationship to immunosuppressive activity
64. Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import
65. Utilization of an NF-ATp binding promoter element for EGR3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A
66. Cyclosporin A interferes with the inducible degradation of NF-κB inhibitors, but not with the processing of p105/NF-κB1 in T cells
67. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection
68. PMA/ionomycin induces IgK 3' enhancer activity which is in part mediated by a unique NFAT transcription complex
69. c-jun N-terminal kinase is involved in AUUUA-medicated interleukin-3 mRNA turnover in mast cells
70. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity
71. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
72. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
73. Cyclosporine nephrotoxicity
74. Intracellular calcium dependence of gene expression in single T lymphocytes
75. NF-AT components define a family of transcription factors targeted in T-cell activation
76. The transcription factor NFAT4 is involved in the generation and survival of T cells
77. Phosphorylation of the transcription factor NFATp inhibits its DNA binding activity in cyclosporin A-treated human B and T cells
78. Chronic rejection and chronic cyclosporin toxicity in renal allografts
79. Transport routes through the nuclear pore complex
80. Cancers following cyclosporine therapy
81. The transcription factor NF-ATc is essential for cardiac valve formation
82. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc
83. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development
84. Transcription factors of the NFAT family: Regulation and function
85. Cyclospodn A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: A possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-medicated gene expression
86. Protein folding and the regulation of signaling pathways
87. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors
88. The mechanism of action of cyclosporin A and FK506
89. The interleukin 2 receptor α chain/CD25 promoter is a target for nuclear factor of activated T cells
90. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice
91. Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1
92. 2+-dependent calcineurin signaling pathway
93. Immunosuppressive drugs prevent a rapid dephosphorylation of the transcription factor NFATp in stimulated immune cells
94. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
95. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4
96. In vivo expression of transforming growth factor-β1 in humans
97. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechahism of action of cyclosporin A?
98. Neural actions of immunophilin ligands
99. The calcium/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase
100. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation
101. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes
102. Immunosuppressants: Cellular and molecular mechanisms of action
103. NFAT interactions with the vasoactive intestinal peptide cytokine response element
104. 2+ signals and immunosuppression
105. Regulation of NF-κB, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-κB p50
106. Protein kinase C and calcineurin synergize to activate IκB kinase and NF-κB in T lymphocytes
107. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation
108. Molecular regulation of cytokine gene expression during the immune response
109. Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: Role of interleukin-4 (IL-4) and IL-5
110. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes
111. Mechanisms of Wnt signaling in development
112. An enhanced immune response in mice lacking the transcription factor NFAT1
113. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production
114. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th1 cells and controls Th2-specific expression of the Interleukin-5 gene
115. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3
116. NF-AT activation requires suppression of Crm1-dependent export by calcineurin
117. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1